Clinical Trials Logo

Clinical Trial Summary

The prevalence of a traumatic brain injury (TBI) in children and adolescents is around 30% with 70-90% being classified as mild (concussion). Because the brain of a child is still developing, a TBI can have devastating effects and possibly creates lifetime challenges. Sleep seems to play an important role in the post-concussion recovery process. Auditory stimulation during sleep has been shown to reliably boost slow waves, a solid marker for the depth of sleep, and can thus be used to deepen sleep. This study aims to investigate the effects of sleep enhancement via auditory stimulation on recovery after a concussion in children and adolescents in their home. Therefore, half of the patients receive one week of auditory stimulation during deep sleep at their home using a mobile device. The other half follows the same study protocol, but no tones are administered (sham). Cognitive tests as well as symptom questionnaires are used to assess the recovery process. It is hypothesized that the patients in the intervention group will recover better than the ones who haven't received the intervention. Additionally, a group of children and adolescents who never sustained a concussion is included as a control.


Clinical Trial Description

In total, 120 participants are planned: 60 patients (30 intervention, 30 sham) and 60 controls (30 intervention, 30 sham). This was estimated from a power analysis and based on previous results. Patients are recruited from the University Children's Hospital Zurich. At first, the participants will complete a baseline assessment of neuropsychological measures (cognitive tests and questionnaires). After completion of the baseline assessment, the participants receive deep sleep enhancement with auditory stimulation for seven nights, but half of them will only receive sham stimulation (device application, but no stimulation). Additionally, they wear an actigraph throughout the whole week. Afterwards, they fill in again some questionnaires (intermediate assessment). One month after study inclusion, the first follow-up will take place where neuropsychological and (optionally) neurological measures will be collected. The second follow-up takes place six months after study inclusion and involves again filling in questionnaires about post-concussive symptoms. The study will be monitored regularly in terms of data validation and source data verification. Adverse events and device deficiencies are carefully documented and reported according to the guidelines of swissmedic and the responsible ethics committee. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04770116
Study type Interventional
Source University Children's Hospital, Zurich
Contact Reto Huber, Prof.
Phone 0041442668160
Email reto.huber@kispi.uzh.ch
Status Recruiting
Phase N/A
Start date May 31, 2021
Completion date May 2024

See also
  Status Clinical Trial Phase
Completed NCT03475693 - A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in Adolescents Early Phase 1
Completed NCT04106154 - Impacting Children's Physical and Mental Health Through Kinesiology Support in Clinical Care N/A
Not yet recruiting NCT03355339 - The Effect of Binasal Occlusion on Balance Following a Concussion N/A
Active, not recruiting NCT05173818 - Hyperbaric Oxygen Effects on Persistent Post-concussive Symptoms Phase 2
Recruiting NCT03759808 - Treatment for Patients With Chronic Post-Concussion Symptoms N/A
Completed NCT05399849 - Mindfulness Intervention in Young Adults With a Concussion History N/A
Enrolling by invitation NCT03695042 - Blood Flow Restriction Concussion N/A
Not yet recruiting NCT05660356 - Growth Hormone Deficiency in Mild Traumatic Brain Injury Early Phase 1
Terminated NCT04226365 - Pediatric Concussion Outcomes Phase 4